TXG logo

TXG

10x Genomics Inc.

$13.04
$0.00(0.00%)
54
Overall
--
Value
54
Tech
--
Quality
Market Cap
$1.62B
Volume
1.92M
52W Range
$6.78 - $23.16
Target Price
$14.61
Order:

Income Statement

MetricTrendChart
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$245.9M$298.8M$490.5M$516.4M$618.7M$610.8M
Total Revenue
$245.9M$298.8M$490.5M$516.4M$618.7M$610.8M
COST OF GOODS SOLD
Cost of Revenue
$61.0M$58.5M$74.1M$120.4M$209.4M$196.3M
GROSS PROFIT
Gross Profit
$184.9M$240.4M$416.4M$396.0M$409.3M$414.5M
OPERATING EXPENSES
Operating Expenses
$215.4M$774.5M$468.7M$564.0M$674.6M$609.0M
Research & Development
$83.1M$570.9M$211.8M$265.7M$270.3M$264.7M
Research Expense
$83.1M$570.9M$211.8M$265.7M$270.3M$264.7M
Selling, General & Administrative
$130.8M$202.3M$331.7M$298.3M$343.3M$344.3M
Selling & Marketing Expenses
$1.5M$1.9M$4.7M$3.7M$3.3M$3.9M
General & Administrative Expenses
$130.8M$202.3M$331.7M$298.3M$343.3M$344.3M
Promotion & Advertising
$1.5M$1.9M$4.7M------
Depreciation & Amortization
$61.0M$12.3M$18.5M$22.8M$32.9M$33.9M
Depreciation & Amortization
$61.0M$12.3M$18.5M------
Amortization
$61.0M$1.8M$4.5M$4.5M$4.5M$1.6M
Other Operating Expenses
$-2.2M$-8.6M$-9.4M------
OPERATING INCOME
Operating income
$-30.6M$-534.1M$-52.3M$-167.9M$-265.3M$-194.6M
EBITDA
$-20.8M$-513.8M$-24.6M$-128.5M$-205.1M$-134.0M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$3.1M$1.7M$866.0K$476.0K$33.0K$4.0K
Intinc
$2.8M$1.5M$206.0K$6.6M$16.9M$18.4M
Net Non-Operating Interest Income/Expense
$-274.0K$-150.0K$-660.0K$6.2M$16.9M$18.4M
Other Income/Expense
$186.0K$184.0K$802.0K$-198.0K$307.0K$1.6M
Other Special Charges
$-186.0K$-184.0K$-802.0K$-198.0K$-307.0K$-1.6M
SPECIAL ITEMS
Special Income Charges
$-61.0M----$-4.2M$-2.5M$-259.0K
PRE-TAX INCOME
EBIT
$-28.0M$-474.3M$-52.8M$-161.5M$-248.7M$-177.7M
Pre-Tax Income
$-31.0M$-534.5M$-53.7M$-162.0M$-248.8M$-177.7M
INCOME TAX
Tax Provision
$218.0K$8.3M$4.5M$4.0M$6.3M$4.9M
NET INCOME
Net Income
$-31.3M$-542.7M$-58.2M$-166.0M$-255.1M$-182.6M
Net Income (Continuing Operations)
$-31.3M$-542.7M$-58.2M$-166.0M$-255.1M$-182.6M
Net Income (Discontinued Operations)
$-31.3M$-542.7M$-58.2M$-166.0M$-255.1M$-182.6M
Net Income (Common Stockholders)
$-31.3M$-542.7M$-58.2M$-166.0M$-255.1M$-182.6M
TOTALS
Total Expenses
$276.5M$833.0M$542.7M$684.4M$884.1M$805.3M
SHARE & EPS DATA
Average Shares Outstanding
$39.1M$101.2M$110.3M$113.9M$117.2M$120.5M
Average Shares Outstanding (Diluted)
$39.1M$101.2M$110.3M$113.9M$117.2M$120.5M
Shares Outstanding
$96.6M$108.8M$114.4M$115.4M$119.2M$122.3M
Basic EPS
$-0.80$-5.37$-0.53$-1.46$-2.18$-1.52
Basic EPS (Continuing Operations)
$-0.80$-5.37$-0.53$-1.46$-2.18$-1.52
Diluted EPS
$-0.80$-5.37$-0.53$-1.46$-2.18$-1.52
Diluted EPS (Continuing Operations)
----$-0.53$-1.46$-2.18$-1.52
OTHER METRICS
Interest Expense Operating
--$58.5M--------
Loss And Loss Adjustment Expected Incurred
$1.5M$1.3M$-660.0K------
Non Recurring Operation Expense
$61.0M----------
Other Gand A
$130.8M$202.3M$331.7M$298.3M$343.3M$344.3M
Rent And Landing Fees
$6.8M----------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2TXG$13.040%1.92M
3
4
5
6

Get 10x Genomics Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.